Arcis Biotechnology Crowdfunds on Capital Cell, Seeks £1.75 Million

Arcis Biotechnology is crowdfunding on Capital Cell now having already raised £1.25 million. The company is hoping to raise £1.75 million at a pre-money valuation of £18.2 million.

Capital Cell “endorses” this company and has posted the following statement:

“Arcis’ technology allows the extraction of DNA and RNA from various sample types (human, animal, plant or pathogen) in under three minutes. This is significantly faster than the current laboratory standard of 45 minutes to an hour. On top of that their system allows for the safe and stable storage of the nucleic acids at room temperature until ready for amplification (the multiplication of DNA/RNA for further downstream testing). The Arcis team is highly knowledgeable, with experience in the development and commercialisation of medical devices, among many other areas. Their platform technology can be applied to many different and growing markets and their product is market ready with two launched CE-IVD regulated products. They have a clear exit strategy, with a mission to sell the Arcis technology and patents to a global Life Sciences company.”

The Biotech early stage sector is tough because the runway from concept to widespread adoption can be quite long.

One of the important aspects of the is security offering is the fact any investment includes some shareholder rights everyone should expect such as: Drag Along/Tag Along and Voting Rights.

If things go well, the expectation is for an exit to take place by 2021 to 2o24.

Peter Whitehurst, CEO, Arcis Biotechnology, commented on the offering:

“The Arcis technology has a strong IP portfolio, and has received a great deal of interest from commercial partners looking to negotiate a licence or OEM deal. We took the decision to work with Capital Cell due to their innovative approach, and their network of specialist life sciences investors. We look forward to working with the team to help fund the next exciting stage of Arcis’ development.”

 


Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!



Sponsored Links by DQ Promote

 

 

Disclosure Quest

Reg A - Form 1-A Filings Beta

Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.

YTD: Jan 1, 2026 - Nov 17, 2026 vs Jan 1, 2025 - Nov 17, 2025

Share this graph
Number of Filings138Prior 131 +5.3%
Target Raise, Total$3.49BPrior $3.62B -3.7%
This YTDYear priorChange
Filings 138 131 +5.3%
Target raise $3.49B $3.62B -3.7%

Sponsored by the Crowded Media Group the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us @CrowdfundInside

Source: DisclosureQuest. Initial Form 1-A only.

Created by Crowded Media Group

This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.

0 0 votes
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Newest
Oldest Most Voted
 
0
Would love your thoughts, please comment.x
()
x
Send this to a friend